vs
CPI AEROSTRUCTURES INC（CVU）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是CPI AEROSTRUCTURES INC的1.8倍（$35.5M vs $19.4M），CPI AEROSTRUCTURES INC净利率更高（3.6% vs -304.2%，领先307.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -10.8%），CPI AEROSTRUCTURES INC自由现金流更多（$-2.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 0.9%）
CPI航空结构公司（简称CPI Aero）总部位于美国纽约州埃德伍德国，是一家专业承接定制订单的飞机零部件制造商，专注为航空领域客户供应航空结构组件。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CVU vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.8倍
$19.4M
营收增速更快
RXRX
高出692.6%
-10.8%
净利率更高
CVU
高出307.8%
-304.2%
自由现金流更多
CVU
多$45.2M
$-47.3M
两年增速更快
RXRX
近两年复合增速
0.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.4M | $35.5M |
| 净利润 | $691.8K | $-108.1M |
| 毛利率 | 20.3% | 59.8% |
| 营业利润率 | 6.4% | -304.8% |
| 净利率 | 3.6% | -304.2% |
| 营收同比 | -10.8% | 681.7% |
| 净利润同比 | -28.8% | 39.6% |
| 每股收益（稀释后） | $0.04 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVURXRX
| Q4 25 | $19.4M | $35.5M | ||
| Q3 25 | $19.3M | $5.2M | ||
| Q2 25 | $15.2M | $19.2M | ||
| Q1 25 | $15.4M | $14.7M | ||
| Q4 24 | $21.8M | $4.5M | ||
| Q3 24 | $19.4M | $26.1M | ||
| Q2 24 | $20.8M | $14.4M | ||
| Q1 24 | $19.1M | $13.8M |
净利润CVURXRX
| Q4 25 | $691.8K | $-108.1M | ||
| Q3 25 | $1.1M | $-162.3M | ||
| Q2 25 | $-1.3M | $-171.9M | ||
| Q1 25 | $-1.3M | $-202.5M | ||
| Q4 24 | $971.5K | $-178.9M | ||
| Q3 24 | $749.7K | $-95.8M | ||
| Q2 24 | $1.4M | $-97.5M | ||
| Q1 24 | $168.2K | $-91.4M |
毛利率CVURXRX
| Q4 25 | 20.3% | 59.8% | ||
| Q3 25 | 22.3% | -183.8% | ||
| Q2 25 | 4.4% | -4.9% | ||
| Q1 25 | 10.7% | -48.0% | ||
| Q4 24 | 20.0% | -181.4% | ||
| Q3 24 | 21.7% | 53.7% | ||
| Q2 24 | 24.6% | 36.2% | ||
| Q1 24 | 18.6% | 19.1% |
营业利润率CVURXRX
| Q4 25 | 6.4% | -304.8% | ||
| Q3 25 | 9.1% | -3327.6% | ||
| Q2 25 | -13.1% | -916.8% | ||
| Q1 25 | -7.7% | -1297.9% | ||
| Q4 24 | 9.5% | -4042.4% | ||
| Q3 24 | 7.6% | -377.1% | ||
| Q2 24 | 11.2% | -697.4% | ||
| Q1 24 | 4.4% | -698.4% |
净利率CVURXRX
| Q4 25 | 3.6% | -304.2% | ||
| Q3 25 | 5.8% | -3135.3% | ||
| Q2 25 | -8.7% | -894.2% | ||
| Q1 25 | -8.6% | -1373.3% | ||
| Q4 24 | 4.5% | -3935.5% | ||
| Q3 24 | 3.9% | -367.5% | ||
| Q2 24 | 6.8% | -676.6% | ||
| Q1 24 | 0.9% | -662.4% |
每股收益（稀释后）CVURXRX
| Q4 25 | $0.04 | $-0.17 | ||
| Q3 25 | $0.09 | $-0.36 | ||
| Q2 25 | $-0.10 | $-0.41 | ||
| Q1 25 | $-0.10 | $-0.50 | ||
| Q4 24 | $0.08 | $-0.56 | ||
| Q3 24 | $0.06 | $-0.34 | ||
| Q2 24 | $0.11 | $-0.40 | ||
| Q1 24 | $0.01 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | $0 | $9.6M |
| 股东权益账面价值 | $25.8M | $1.1B |
| 总资产 | $75.2M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资CVURXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务CVURXRX
| Q4 25 | $0 | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $26.5K | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益CVURXRX
| Q4 25 | $25.8M | $1.1B | ||
| Q3 25 | $25.0M | $1.0B | ||
| Q2 25 | $23.8M | $919.1M | ||
| Q1 25 | $24.9M | $933.9M | ||
| Q4 24 | $25.9M | $1.0B | ||
| Q3 24 | $24.9M | $524.6M | ||
| Q2 24 | $24.1M | $584.4M | ||
| Q1 24 | $22.5M | $401.2M |
总资产CVURXRX
| Q4 25 | $75.2M | $1.5B | ||
| Q3 25 | $74.1M | $1.4B | ||
| Q2 25 | $72.3M | $1.3B | ||
| Q1 25 | $65.4M | $1.3B | ||
| Q4 24 | $68.0M | $1.4B | ||
| Q3 24 | $68.9M | $726.5M | ||
| Q2 24 | $70.2M | $775.9M | ||
| Q1 24 | $70.8M | $557.8M |
负债/权益比CVURXRX
| Q4 25 | 0.00× | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 0.00× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-2.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | -10.8% | -133.1% |
| 资本支出强度资本支出/营收 | 0.0% | 3.5% |
| 现金转化率经营现金流/净利润 | -3.03× | — |
| 过去12个月自由现金流最近4个季度 | $-5.3M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流CVURXRX
| Q4 25 | $-2.1M | $-46.1M | ||
| Q3 25 | $212.1K | $-117.4M | ||
| Q2 25 | $-596.3K | $-76.4M | ||
| Q1 25 | $-2.7M | $-132.0M | ||
| Q4 24 | $4.4M | $-115.4M | ||
| Q3 24 | $715.1K | $-59.2M | ||
| Q2 24 | $-591.7K | $-82.2M | ||
| Q1 24 | $-960.5K | $-102.3M |
自由现金流CVURXRX
| Q4 25 | $-2.1M | $-47.3M | ||
| Q3 25 | $211.1K | $-117.6M | ||
| Q2 25 | $-599.8K | $-79.6M | ||
| Q1 25 | $-2.8M | $-133.8M | ||
| Q4 24 | $4.3M | $-116.7M | ||
| Q3 24 | $586.9K | $-63.8M | ||
| Q2 24 | $-746.9K | $-83.4M | ||
| Q1 24 | $-1.0M | $-109.0M |
自由现金流率CVURXRX
| Q4 25 | -10.8% | -133.1% | ||
| Q3 25 | 1.1% | -2272.5% | ||
| Q2 25 | -4.0% | -413.9% | ||
| Q1 25 | -18.1% | -907.4% | ||
| Q4 24 | 19.9% | -2567.7% | ||
| Q3 24 | 3.0% | -244.6% | ||
| Q2 24 | -3.6% | -578.5% | ||
| Q1 24 | -5.3% | -789.9% |
资本支出强度CVURXRX
| Q4 25 | 0.0% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.4% | 12.4% | ||
| Q4 24 | 0.3% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 0.7% | 8.2% | ||
| Q1 24 | 0.2% | 48.2% |
现金转化率CVURXRX
| Q4 25 | -3.03× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.42× | — | ||
| Q1 24 | -5.71× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVU
| Government Subcontracts | $16.4M | 85% |
| Commercial Contracts | $2.3M | 12% |
| Prime Government Contracts | $725.8K | 4% |
RXRX
暂无分部数据
